Welcome to GenPrice! Check out our latest updates.

Shopping Cart (0)

Your cart is empty

Add some products to get started!

CC214-2

Product Specifications

UNSPSC Description

CC214-2 is an oral active and selective mTOR kinase inhibitor. CC214-2 targets to both of mTORC1 (pS6) and mTORC2 (pAktS473). CC214-2 induces autophagy, which is a potential target for host-directed therapy (HDT) in tuberculosis. CC214-2 exhibits synergistic bactericidal and sterilizing activity agasinst tuberculosis (TB), and shortens the treatment duration. CC214-2 also inhibits Rapamycin (HY-10219)-resistant signaling and the growth of glioblastomas in vitro and in vivo[1][2].

Target Antigen

Autophagy; mTOR

Type

Reference compound

Related Pathways

Autophagy;PI3K/Akt/mTOR

Applications

Cancer-Kinase/protease

Field of Research

Cancer

Assay Protocol

https://www.medchemexpress.com/cc214-2.html

Solubility

DMSO : 12.5 mg/mL (ultrasonic;warming;heat to 80°C)

Smiles

O=C1N=C2NC=C(C3=CC=C(C(C)(C)O)N=C3)N=C2N(CC4CCOCC4)C1

Molecular Weight

383.44

References & Citations

[1]Tasneen R, et al. Dual mTORC1/mTORC2 Inhibition as a Host-Directed Therapeutic Target in Pathologically Distinct Mouse Models of Tuberculosis. Antimicrob Agents Chemother. 2021;65(7):e0025321.|[2]Gini B, et al. The mTOR kinase inhibitors, CC214-1 and CC214-2, preferentially block the growth of EGFRvIII-activated glioblastomas. Clin Cancer Res. 2013 Oct 15;19(20):5722-32.

Shipping Conditions

Room Temperature

Product Datasheet

http://file.medchemexpress.com/batch_PDF/HY-145931/CC214-2-DataSheet-MedChemExpress.pdf

Product MSDS

http://file.medchemexpress.com/batch_PDF/HY-145931/CC214-2-SDS-MedChemExpress.pdf

Clinical Information

No Development Reported

CAS Number

1228012-18-7

Available Sizes

Curated Selection

Explore Other Products

Discover premium biology products from our extensive collection of 20M+ items

Recombinant Human Sphingolipid delta (4)-desaturase DES1 (DEGS1), partial
MBS7054636-01 0.02 mg (E-Coli)

Recombinant Human Sphingolipid delta (4)-desaturase DES1 (DEGS1), partial

Ask
View Details
Recombinant Human Sphingolipid delta (4)-desaturase DES1 (DEGS1), partial
MBS7054636-02 0.1 mg (E-Coli)

Recombinant Human Sphingolipid delta (4)-desaturase DES1 (DEGS1), partial

Ask
View Details
Recombinant Human Sphingolipid delta (4)-desaturase DES1 (DEGS1), partial
MBS7054636-03 0.02 mg (Yeast)

Recombinant Human Sphingolipid delta (4)-desaturase DES1 (DEGS1), partial

Ask
View Details
Recombinant Human Sphingolipid delta (4)-desaturase DES1 (DEGS1), partial
MBS7054636-04 0.1 mg (Yeast)

Recombinant Human Sphingolipid delta (4)-desaturase DES1 (DEGS1), partial

Ask
View Details
Recombinant Human Sphingolipid delta (4)-desaturase DES1 (DEGS1), partial
MBS7054636-05 0.02 mg (Baculovirus)

Recombinant Human Sphingolipid delta (4)-desaturase DES1 (DEGS1), partial

Ask
View Details
Recombinant Human Sphingolipid delta (4)-desaturase DES1 (DEGS1), partial
MBS7054636-06 1 mg (E-Coli)

Recombinant Human Sphingolipid delta (4)-desaturase DES1 (DEGS1), partial

Ask
View Details